Held August 14–16, 2026 at the China National Convention Center in Beijing, China-Hospeq 2026 convened official delegations from the GCC, African Union, SCO and ASEAN member states. The Kingsung Medical booth naturally evolved into a de facto international technical exchange salonon the show floor.

On display was the Company’s full flagship portfolio: the PGA Absorbable Nerve Conduit—the first domestically commercialized nerve conduit endorsed by China’s National “973” Basic Research Program; the “Koupler” Microvascular Anastomotic Coupler 2.0, the world’s second and China’s first-of-its-kind anastomotic device, demonstrated live through on-site physical teardown and hands-on procedural drills; together with the Tension Controlled Dermal Closure Device and companion microsurgical staples. Delegates from multiple countries lingered for in-depth technical dialogue, with several already signaling preliminary intent for joint research programs and product import partnerships.

Faculty experts widely endorsed Kingsung’s “product-plus-academia” dual-engine model—recognizing that the Company pursues not only discrete technological breakthroughs, but sustains long-term ecosystem building for microsurgery and nerve repair disciplines. Backed by 180+ granted patents and a recently closed over-100-million-RMB Series A financing round, Kingsung leveraged this global showcase to bring Chinese smart manufacturing in polymer science and micron-level precision mechanics to an overseas audience—translating booth conversations into tangible, bankable momentum for premium domestic device export. Moving forward, innovation remains the compass as more “China-originated” surgical solutions advance onto the world stage.
